- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05799937
Effect of Smoking on Periapical Healing After NSRCT
To Evaluate the Effect of Smoking on Periapical Healing After Non Surgical Root Canal Treatment- a Prospective Cohort Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The clinical and radiological success of primary non-surgical endodontic treatment in smoker & nonsmoker patients will be compared between both groups and smoking cessation effect on periapical healing will be assessed.
The correlation between the self-reported smoking status & smoking status by urine analysis
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Haryana
-
Rohtak, Haryana, India, 124001
- PGIDS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- systemically healthy patients of age 18 years and above, known current smoker patient , a non-smoker or former smoker patient ,should have at least minimum 8 teeth in oral cavity, requiring periapical radiographs of teeth with periapical pathosis
Exclusion Criteria:
- Pregnant or patient having systemic disorders, those patients who are non-compliant and not maintaining oral hygiene, teeth requiring retreatment and having procedural errors. Teeth that are not suitable for rubber dam isolation, teeth that have advanced periodontal disease and having endo-perio lesions and, patients requiring endocarditis prophylaxis
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group-A Smokers
smoker patients will be recruited in this group
|
After administration of LA and rubber dam isolation, access cavity will be prepared using carbide burs in high speed hand piece with copious irrigation.
Working length will be determined using root ZX apex locator and will be verified radiographically.
Canal preparation will be done with rotary instruments .
5ml of 5.25% NaOCl will be used as irrigant after each instrument.
After instrumentation , the canals will be irrigated with 5.0 ml of 17% EDTA for 1minute followed by irrigation with 5.0 ml of 5.25% NaOCl.
Canals will be dried with absorbent paper points, filled with calcium hydroxide paste and access cavity will be restored with IRM.
Patients will be recalled after 1 week.At the next appointment, after paste removal, copious irrigation with 5.25% NaOCl will be done and canals will be dried with paper points.
Canals will be obturated with Gutta-Percha and ZOE based sealer.
|
|
Group-B Non-Smokers
non smokers or patients who had quit smoking will be recruited in this group
|
After administration of LA and rubber dam isolation, access cavity will be prepared using carbide burs in high speed hand piece with copious irrigation.
Working length will be determined using root ZX apex locator and will be verified radiographically.
Canal preparation will be done with rotary instruments .
5ml of 5.25% NaOCl will be used as irrigant after each instrument.
After instrumentation , the canals will be irrigated with 5.0 ml of 17% EDTA for 1minute followed by irrigation with 5.0 ml of 5.25% NaOCl.
Canals will be dried with absorbent paper points, filled with calcium hydroxide paste and access cavity will be restored with IRM.
Patients will be recalled after 1 week.At the next appointment, after paste removal, copious irrigation with 5.25% NaOCl will be done and canals will be dried with paper points.
Canals will be obturated with Gutta-Percha and ZOE based sealer.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Radiographic healing
Time Frame: 12 months
|
Radiographic healing measured by change in ize of apical radiolucency assessed by Periodical index (PAI) . PAI score 1 and 2 are classified as healed and PAI score 3,4,and 5 as unhealed. |
12 months
|
|
Clinical Success
Time Frame: 12 month
|
Absence of clinical signs and symptoms such as spontaneous pain, presence of sinus tract, swelling, mobility, or sensitivity to percussion or palpation
|
12 month
|
Collaborators and Investigators
Investigators
- Study Director: Dr. Sanjay Tewari, MDS, Post Graduate Institute Of Dental Sciences,Rohtak
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PGIDS/BHRC/21/35
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.